Mazzone, Elena Stacy
 Distribuzione geografica
Continente #
NA - Nord America 470
EU - Europa 409
AS - Asia 196
SA - Sud America 10
AF - Africa 2
Totale 1.087
Nazione #
US - Stati Uniti d'America 464
IT - Italia 180
SG - Singapore 95
SE - Svezia 70
IE - Irlanda 48
ID - Indonesia 37
RU - Federazione Russa 25
CN - Cina 23
DE - Germania 23
FR - Francia 14
GB - Regno Unito 13
IN - India 11
HK - Hong Kong 6
JP - Giappone 5
NL - Olanda 5
CA - Canada 4
CH - Svizzera 4
CO - Colombia 4
FI - Finlandia 4
IL - Israele 4
IR - Iran 4
PE - Perù 4
TR - Turchia 4
CZ - Repubblica Ceca 3
DK - Danimarca 3
ES - Italia 3
BE - Belgio 2
BR - Brasile 2
EG - Egitto 2
HR - Croazia 2
LT - Lituania 2
PA - Panama 2
PL - Polonia 2
PT - Portogallo 2
BG - Bulgaria 1
KR - Corea 1
KZ - Kazakistan 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
UA - Ucraina 1
VN - Vietnam 1
Totale 1.087
Città #
Chandler 108
Ashburn 81
Singapore 77
New York 49
Dublin 40
Jakarta 37
Rome 28
Milan 23
Moscow 14
Palermo 12
Chicago 10
Los Angeles 10
Marseille 10
Pune 10
Princeton 8
Boston 7
San Mateo 7
Munich 6
Secaucus 5
Ancona 4
Edinburgh 4
Fairfield 4
Florence 4
Hong Kong 4
Kiel 4
Lima 4
Santa Clara 4
Shenzhen 4
Tokyo 4
Turin 4
Wilmington 4
Bern 3
Bremen 3
Brno 3
Bucaramanga 3
Busto Arsizio 3
Harrisburg 3
Helsinki 3
London 3
Naples 3
Toronto 3
Triggiano 3
Amsterdam 2
Barbarano Vicentino 2
Beijing 2
Bergamo 2
Boardman 2
Bologna 2
Brussels 2
Cairo 2
Conegliano 2
Copenhagen 2
Frankfurt am Main 2
Genoa 2
Hangzhou 2
Istanbul 2
Kazan' 2
Menlo Park 2
Modena 2
Nus 2
Oegstgeest 2
Perafita 2
Pescara 2
Piacenza 2
Priolo Gargallo 2
Redmond 2
Royal Oak 2
San Francisco 2
San Martino in Rio 2
Sandston 2
Shanghai 2
Springfield 2
Tribano 2
Washington 2
Zagreb 2
Albignasego 1
Almaty 1
Andover 1
Atripalda 1
Bangkok 1
Bari 1
Bisignano 1
Bratislava 1
Breckenridge 1
Buffalo 1
Cattolica 1
Cedar Knolls 1
Central 1
Cinisello Balsamo 1
Deiva Marina 1
Edmonton 1
Forest City 1
Grassobbio 1
Gricignano di Aversa 1
Gunzenhausen 1
Hanoi 1
Kish 1
Klausen 1
Lappeenranta 1
Las Vegas 1
Totale 714
Nome #
Performance of Upper Limb module for Duchenne muscular dystrophy 138
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 81
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 70
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 55
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 52
Clinical Variability in Spinal Muscular Atrophy Type III. 51
Our Experience on Temporal Bone Fractures: Retrospective Analysis of 141 Cases 46
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow up 43
Revised upper limb module for spinal muscular atrophy: Development of a new module 40
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 38
First international workshop on rehabilitation management and clinical outcome measures for spinal muscular atrophy 38
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 37
Sleep disorders in spinal muscular atrophy 33
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy 33
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials 32
Old measures and new scores in spinal muscular atrophy patients 32
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 30
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 28
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 26
Early neurodevelopmental assessment in Duchenne muscular dystrophy 21
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy 21
Emergencies cards for neuromuscular disorders 1st Consensus Meeting from UILDM - Italian Muscular Dystrophy Association Workshop report 20
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 20
Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool 16
Patient reported outcome measure for upper limb in Duchenne muscular dystrophy: correlation with PUL2.0 15
Erratum: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-month changes (PLoS ONE (2015) 10:12 (e0144079)) 15
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 13
Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients 12
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 11
The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability 11
Assessing upper limb function in nonambulant SMA patients: Development of a new module 7
Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 (PLoS ONE (2019) 14:6 (e0218683) DOI: 10.1371/journal.pone.0218683) 7
Daily salbutamol in young patients with SMA type II 6
Correction: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-Month changes 6
Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy 5
Reliability of the North Star Ambulatory Assessment in a multicentric setting 4
Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM 3
Totale 1.116
Categoria #
all - tutte 7.742
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.742


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 1 1 0
2021/202293 11 0 0 19 4 6 3 10 4 6 18 12
2022/2023359 19 30 26 44 30 59 17 34 51 12 20 17
2023/2024467 22 83 12 23 15 87 40 43 11 21 50 60
2024/2025195 22 15 82 25 51 0 0 0 0 0 0 0
Totale 1.116